Augmented Reality Binocular Therapy for Adult Amblyopia
Official title: Augmented Reality-Based Binocular Therapy for Visual Rehabilitation in Adults With Amblyopia
Run by Polytechnic Institute of Porto · NCT07819552 · Data updated 2026-11-12
This trial tests a home-based augmented reality binocular therapy to see if it improves vision in adults 18–40 with anisometropic amblyopia, compared with placebo training.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 40 Years |
| Sex | All |
| Enrollment | 60 (estimated) |
| Sponsor | Polytechnic Institute of Porto Academic / other |
| Locations | 2 sites (Coimbra, Coimbra District and 1 other locations) |
| Status | Recruiting |
| Started | May 1, 2026 |
| Main results expected | January 31, 2028 |
| Study ends | January 31, 2028 |
| Registry record updated | September 18, 2026 |
| Trial ID | NCT07819552 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults aged 18–40 with unilateral anisometropic amblyopia (interocular BCVA difference ≥2 lines and worse-eye BCVA ≤20/32).
✕Probably not a fit
Individuals with amblyopia other than anisometropic, bilateral amblyopia, or other ocular/neuro-ophthalmic conditions may not benefit from this therapy.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
Adults with anisometropic amblyopia will use a mixed-reality headset at home to perform binocular visual training designed to encourage both eyes to contribute. Participants are randomly assigned to active AR binocular therapy or placebo AR visual training, with the same device used in both groups. The study will assess improvements in visual acuity, binocular function, and potential changes in retinal and brain function, plus whether gains persist at 6 months post-treatment.
Why it matters
Potential benefit: If successful, the therapy could improve visual acuity and binocular vision in adults with anisometropic amblyopia and offer a convenient home-based treatment option.
How similar studies have gone: Previous binocular/dichoptic approaches have shown promise in adults, though home-based AR implementations are relatively novel and require confirmation.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Age between 18 and 40 years. * Diagnosis of anisometropic amblyopia, defined as unilateral amblyopia with an interocular difference of at least 2 lines in best-corrected visual acuity (BCVA), with BCVA worse than 20/32 in the more affected eye. Exclusion Criteria: * Amblyopia other than anisometropic amblyopia. * Bilateral amblyopia. * Ophthalmologic or neuro-ophthalmologic disease other than amblyopia. * Neurological disease, chronic pharmacological therapy, or implanted medical devices. * Any ocular surgery or ocular treatment within the previous year. * Significant media opacities that may prevent fundus examination. * Inability to provide informed consent.
Where it's running
-
Coimbra Institute for Biomedical Imaging and Translational Research (CIBIT), University of Coimbra
Coimbra, Coimbra District, Portugal Recruiting -
RISE-Health, Center for Translational Health and Medical Biotechnology Research (TBIO), School of Health, Polytechnic of Porto
Porto, Porto District, Portugal Recruiting
Study contacts
- Study coordinator: Catarina A Mateus, PhD
- Email: cms@ess.ipp.pt
- Phone: +351 913474780
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Noninvasive brain stimulation plus augmented reality vision therapy for anisometropic amblyopia in adults
This trial tests whether adding HD-tDCS to AR-based dichoptic therapy can improve vision in adults with anisometropic amblyopia.
-
Psilocybin-assisted therapy to help adults with amblyopia see more clearly
This study tests whether a single or small doses of psilocybin can boost the effectiveness of amblyopia treatment in adults.
-
Gabor-based visual training for adults with amblyopia
This study tests a computer-based Gabor training program to see if it can improve vision in adults aged 18–39 with amblyopia due to anisometropia or strabismus.
-
tDCS for paediatric amblyopia
This study tests whether non-invasive brain stimulation (tDCS) can improve vision for children aged 4–14 with amblyopia who didn’t get enough help from patching.
-
Gamified visual training with occlusion for kids with anisometropic amblyopia
This trial tests two kid-friendly digital games plus patching to see if they improve vision and motivation in children aged 4–7 with anisometropic amblyopia compared with patching alone.
-
Combined fluoxetine and patching to improve and maintain vision in amblyopia using OCTA and VEP
This project will test whether adding fluoxetine to standard eye patching helps improve and maintain vision in people over 10 with amblyopia.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.